Device type · PGX
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PGX
Microbiology
Device class
Class II
FDA decisions since 2015
12
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Product code
- PGX
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2680
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for PGX
Latest FDA decisions
The 8 newest of 12 since 2015.
K260047 · Decided Aug 28, 2026 · 233 days after receipt
Device type: Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System (PGX) · Laboratory Medicine & Pathology
K260333 · Decided Jun 15, 2026 · 133 days after receipt
Device type: Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System (PGX) · Laboratory Medicine & Pathology
- Accula Strep A Test510(k)
K201269 · Decided Nov 9, 2020 · 181 days after receipt
Device type: Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System (PGX) · Laboratory Medicine & Pathology
9 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Xpert Xpress Strep A, XPRSTREPA-10, P/N: 302-2294 IVD, Rx OnlyOpen, Classified
Z-0215-2024 · Started Apr 24, 2023 · Posted by FDA Nov 2, 2023
Reason given: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.
Cause as FDA categorized it: Unknown/Undetermined by firm
- Xpert Xpress Strep A, REF:Xprstrepa-CE-10, CE IVD,Open, Classified
Z-0216-2024 · Started Apr 24, 2023 · Posted by FDA Nov 2, 2023
Reason given: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.
Cause as FDA categorized it: Unknown/Undetermined by firm
- ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469Open, Classified
Z-2286-2019 · Started Feb 20, 2019 · Posted by FDA Aug 15, 2019
Reason given: Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and...
Cause as FDA categorized it: Process control
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.